Trademark: 88241342
Word
TARSAL
Status
Dead
Status Code
606
Status Date
Monday, October 19, 2020
Serial Number
88241342
Mark Type
4000
Filing Date
Wednesday, December 26, 2018
Published for Opposition
Tuesday, January 21, 2020
Abandoned Date
Monday, October 19, 2020

Trademark Owner History
BOTROS , Mina Ashak - Owner At Publication
BOTROS , Ashak Fakous - Owner At Publication
Tarsal Pharmaceuticals Inc. - Owner At Publication

Classifications
5 Dietary supplements; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for urinary health; Dietary supplements in the nature of weight loss powders; Dietary supplements with a cosmetic effect; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Enzyme dietary supplements; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Lecithin for use as a dietary supplement; Natural dietary supplements; Nutraceuticals for use as a dietary supplement; Nutritional and dietary supplements formed and packaged as bars; Ocular pharmaceuticals; Protein dietary supplements; Protein dietary supplements formed and packaged as bars; Soy isoflavone dietary supplements; all of the foregoing excludes goods specifically designed or marketed to treat issues related to the tarsus, or tarsal medical issues

Trademark Events
Oct 19, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 19, 2020
Abandonment - No Use Statement Filed
Mar 17, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 17, 2019
Approved For Pub - Principal Register
Nov 25, 2019
Teas/Email Correspondence Entered
Nov 25, 2019
Correspondence Received In Law Office
Nov 18, 2019
Assigned To Lie
Nov 11, 2019
Notice Of Revival - E-Mailed
Nov 11, 2019
Teas Response To Office Action Received
Nov 11, 2019
Petition To Revive-Granted
Nov 11, 2019
Teas Petition To Revive Received
Oct 23, 2019
Abandonment Notice E-Mailed - Failure To Respond
Oct 23, 2019
Abandonment - Failure To Respond Or Late Response
Mar 27, 2019
Notification Of Non-Final Action E-Mailed
Mar 27, 2019
Non-Final Action E-Mailed
Mar 27, 2019
Non-Final Action Written
Mar 19, 2019
Assigned To Examiner
Jan 16, 2019
New Application Office Supplied Data Entered In Tram
Dec 29, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24